Clinical significance of serum interleukin-6 and −174 G/C promoter polymorphism in Rheumatoid arthritis patients. | Tamer A Gheita,MD أ.د تامرغيته

Clinical significance of serum interleukin-6 and −174 G/C promoter polymorphism in Rheumatoid arthritis patients.

Citation:: Gaber, W., GS Azkalany, T. A. Gheita, and et al, "Clinical significance of serum interleukin-6 and −174 G/C promoter polymorphism in Rheumatoid arthritis patients.", The Egyptian Rheumatologist,, vol. 35, issue 2, pp. 107-113, 2013.